Brian Wright
Stock Analyst at Roth MKM
(0.58)
# 3,735
Out of 4,829 analysts
31
Total ratings
25%
Success rate
-29.16%
Average return
Main Sectors:
Stocks Rated by Brian Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIOX Bioceres Crop Solutions | Maintains: Buy | $20 → $21 | $4.65 | +351.61% | 5 | Feb 9, 2024 | |
| ANDE The Andersons | Reiterates: Buy | $65 | $35.91 | +81.01% | 3 | Feb 6, 2024 | |
| BG Bunge Global | Maintains: Buy | $161 → $138 | $80.15 | +72.18% | 2 | Feb 5, 2024 | |
| ADM Archer-Daniels-Midland Company | Downgrades: Neutral | $98 → $66 | $49.90 | +32.26% | 2 | Jan 22, 2024 | |
| FMC FMC Corporation | Initiates: Buy | $74 | $38.22 | +93.62% | 1 | Jan 4, 2024 | |
| CTVA Corteva | Maintains: Buy | $82 → $63 | $67.96 | -7.30% | 2 | Nov 22, 2023 | |
| LNN Lindsay | Upgrades: Buy | $128 → $150 | $137.81 | +8.85% | 3 | Oct 23, 2023 | |
| PAHC Phibro Animal Health | Reiterates: Buy | $21 | $24.50 | -14.29% | 3 | Sep 1, 2023 | |
| UGRO urban-gro | Reiterates: Buy | $11 | $0.41 | +2,572.50% | 2 | Sep 1, 2023 | |
| XXII 22nd Century Group | Reiterates: Buy | $10,800 | $1.07 | +1,009,245.79% | 2 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $60 | $1.13 | +5,209.73% | 3 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $39 | $2.42 | +1,509.38% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $297 | $321.64 | -7.66% | 1 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $0.76 | +15,731.13% | 1 | Oct 8, 2021 |
Bioceres Crop Solutions
Feb 9, 2024
Maintains: Buy
Price Target: $20 → $21
Current: $4.65
Upside: +351.61%
The Andersons
Feb 6, 2024
Reiterates: Buy
Price Target: $65
Current: $35.91
Upside: +81.01%
Bunge Global
Feb 5, 2024
Maintains: Buy
Price Target: $161 → $138
Current: $80.15
Upside: +72.18%
Archer-Daniels-Midland Company
Jan 22, 2024
Downgrades: Neutral
Price Target: $98 → $66
Current: $49.90
Upside: +32.26%
FMC Corporation
Jan 4, 2024
Initiates: Buy
Price Target: $74
Current: $38.22
Upside: +93.62%
Corteva
Nov 22, 2023
Maintains: Buy
Price Target: $82 → $63
Current: $67.96
Upside: -7.30%
Lindsay
Oct 23, 2023
Upgrades: Buy
Price Target: $128 → $150
Current: $137.81
Upside: +8.85%
Phibro Animal Health
Sep 1, 2023
Reiterates: Buy
Price Target: $21
Current: $24.50
Upside: -14.29%
urban-gro
Sep 1, 2023
Reiterates: Buy
Price Target: $11
Current: $0.41
Upside: +2,572.50%
22nd Century Group
Aug 23, 2023
Reiterates: Buy
Price Target: $10,800
Current: $1.07
Upside: +1,009,245.79%
Jul 21, 2023
Maintains: Buy
Price Target: $10 → $60
Current: $1.13
Upside: +5,209.73%
Apr 3, 2023
Maintains: Buy
Price Target: $78 → $39
Current: $2.42
Upside: +1,509.38%
Jun 3, 2022
Initiates: Buy
Price Target: $297
Current: $321.64
Upside: -7.66%
Oct 8, 2021
Initiates: Buy
Price Target: $120
Current: $0.76
Upside: +15,731.13%